These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Long-term outcome of pharmacological and nonpharmacological treatment for ventricular arrhythmias]. Ohnishi S; Kasanuki H J Cardiol; 2000 Mar; 35 Suppl 1():75-84. PubMed ID: 10834174 [TBL] [Abstract][Full Text] [Related]
3. Initial clinical experience with endocardial defibrillation using an implantable cardioverter/defibrillator with a triple-electrode system. Saksena S; Tullo NG; Krol RB; Mauro AM Arch Intern Med; 1989 Oct; 149(10):2333-9. PubMed ID: 2802898 [TBL] [Abstract][Full Text] [Related]
4. Surgical decisions in the management of sudden cardiac death and malignant ventricular arrhythmias. Subendocardial resection, the automatic internal defibrillator, or both. Hargrove WC; Josephson ME; Marchlinski FE; Miller JM J Thorac Cardiovasc Surg; 1989 Jun; 97(6):923-8. PubMed ID: 2724998 [TBL] [Abstract][Full Text] [Related]
5. The automatic implantable cardioverter defibrillator as a therapeutic modality for recurrent ventricular tachycardia: a case study. Kuiper RA Prog Cardiovasc Nurs; 1990; 5(1):6-12. PubMed ID: 2367517 [TBL] [Abstract][Full Text] [Related]
6. Current role of the automatic implantable cardioverter-defibrillator in the treatment of life-threatening ventricular arrhythmias. Kay GN; Plumb VJ; Dailey SM; Epstein AE Am J Med; 1990 Jan; 88(1N):25N-34N. PubMed ID: 2195882 [TBL] [Abstract][Full Text] [Related]
7. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators. Bardy GH; Yee R; Jung W J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117 [TBL] [Abstract][Full Text] [Related]
8. [Combination use of an automatic anti-tachycardia pacemaker and an automatic implantable cardioverter-defibrillator in sustained recurrent ventricular tachycardia resistant to drugs]. Benedini G; Caradonna E; Alfieri O; Visioli O G Ital Cardiol; 1989 Oct; 19(10):889-900. PubMed ID: 2612809 [TBL] [Abstract][Full Text] [Related]
9. A Canadian hospital's experience with the automatic implantable cardioverter/defibrillator. Sharma AD; Guiraudon G; Klein GJ; Yee R CMAJ; 1987 Nov; 137(9):809-15. PubMed ID: 3442769 [TBL] [Abstract][Full Text] [Related]
14. [Implantable defibrillators]. Klein H; Trappe HJ Z Gesamte Inn Med; 1992 May; 47(5):209-17. PubMed ID: 1615731 [TBL] [Abstract][Full Text] [Related]
15. Clinical experience with the automatic implantable defibrillator. Mirowski M; Reid PR; Mower MM; Watkins L; Platia EV; Griffith LS; Veltri EP; Guarnieri T; Juanteguy JM Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():39-42. PubMed ID: 3938257 [TBL] [Abstract][Full Text] [Related]
16. [Experience with the use of an implantable automatic cardioverter defibrillator]. Dórticos F; Zayas R; Dorantes M; Tain J; Bueno J; Carballido J; Sainz H Arch Inst Cardiol Mex; 1990; 60(5):499-502. PubMed ID: 2091555 [TBL] [Abstract][Full Text] [Related]
17. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. Proclemer A; Ghidina M J Cardiovasc Med (Hagerstown); 2007 May; 8(5):320-3. PubMed ID: 17443096 [No Abstract] [Full Text] [Related]
18. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations). Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697 [TBL] [Abstract][Full Text] [Related]
19. [Variables of arrhythmia risk in relation to pacemaker and implantable defibrillator]. Solano A; Oddone D; Croci F; Donateo P; Puggioni E; Brignole M Ital Heart J Suppl; 2001 Dec; 2(12):1303-7. PubMed ID: 11838352 [TBL] [Abstract][Full Text] [Related]
20. Automatic implantable defibrillator for the patient with recurrent refractory malignant ventricular arrhythmias: case report. Stack JM; Houston C; Mirowski M; Mower M; Watkins L; Reid PR Heart Lung; 1982; 11(6):512-5. PubMed ID: 6922850 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]